Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Xylulose kinase (XYLB) is an enzyme that catalyzes the ATP-dependent phosphorylation of D-xylulose to yield D-xylulose 5-phosphate, an important intermediate in the pentose phosphate pathway and glucuronate-xylulose pathway[1][2][5][7]. In mammals, it is predominantly expressed in the liver and kidney and may play regulatory roles in glucose metabolism and lipogenesis via its product, xylulose 5-phosphate[1][7]. The enzyme belongs to the sugar kinase/hsp70/actin superfamily of transferases, with close homology to glycerol kinase[1][2]. Deficiencies or altered expression of xylulose kinase have been associated with conditions such as pentosuria, and it is considered functionally important in energy homeostasis and metabolic regulation[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Xylulose kinase (XYLB).